title: Hypertension: is the sham procedure 'toxic' for renal denervation?
abstract: The announcement by Medtronic that the SYMPLICITY HTN-3 trial failed to meet its primary effectiveness end point calls the blood pressure lowering effects of renal denervation into question. However, its safety is proven, which raises the possibility that the procedure might have beneficial effects on the kidneys beyond blood pressure reduction.
authors.affiliation: First Cardiology Clinic, University of Athens, Hippokration Hospital, 114 Vassilissis Sofias Avenue, 11527 Athens, Greece.
authors.forename: Costas
authors.initials: C
authors.lastname: Tsioufis
mesh_terms: D001794:Blood Pressure; D003714:Denervation; D006801:Humans; D006973:Hypertension / Q000628:therapy*; D007668:Kidney / Q000294:innervation*; D016032:Randomized Controlled Trials as Topic